News Releases

Press Releases

  • 5/22/17 4:05 pm EDT

    Conference call to be held May 31, 2017 at 4:30 p.m. Eastern time

    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced financial results for the three months ended March 31, 2017 and provided a business update. “During the first quarter we continued to make solid progress in advancing our growth strategy and multiproduct pipeline towards commercialization, utilizing our capital- and time-efficient business model,” said Lishan Aklog, M.D.,more...
  • 5/16/17 4:35 pm EDT
    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (NASDAQ:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will postpone its business update conference call to May 31, 2017 at 4:30 p.m. Eastern time. The call had originally been set for May 17, 2017 at 4:30 p.m. Eastern time. Lishan Aklog, M.D., the Company’s Chairman and Chief Executive Officer, and Brian de Guzman, M.D., the Company’s Chief Medical Officer, willmore...
  • 5/10/17 8:30 am EDT
    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on May 17, 2017 at 4:30 p.m. Eastern time. During this call Lishan Aklog, M.D., the Company’s Chairman and Chief Executive Officer, and Brian de Guzman, M.D., the Company’s Chief Medical Officer, will provide a business update including an overview of the Company’s near-term milestones andmore...
  • 4/10/17 4:52 pm EDT

    Exchange Structured to Reward Current Security Holders and Incentivize Long-term Ownership by Both Existing and New Investors

    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it filed a registration statement on Form S-4 with the Securities and Exchange Commission relating to the Company’s previously announced intention to effectuate a registered exchange offer (the “Exchange”) whereby PAVmed’s Common Stock will become exchangeable for units (the “New Units”). Pursuant to the Exchange, eachmore...
  • 3/31/17 9:00 am EDT

    Company Presentation Set for April 4 th at 12:50 p.m. ET

    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq:PAVM)(Nasdaq:PAVMW), a highly differentiated, multi-product medical device company, today announced a revised time for the Company’s presentation at the 16th Annual Needham Healthcare Conference. Lishan Aklog, M.D., chief executive officer will provide a corporate overview, discuss the Company’s innovative business model and review PAVmed’s lead products on Tuesday, April 4, 2017 at 12:50 p.m. Eastern Time. The conference ismore...
  • 3/28/17 7:30 am EDT
    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer, will present at the 16th Annual Needham Healthcare Conference on Wednesday, April 5, 2017, at 10:20 a.m. Eastern time. Dr. Aklog will provide a corporate overview, discuss the company’s innovative business model and review PAVmed’s lead products. The conferencemore...
  • 3/28/17 7:15 am EDT

    No Securities Available for Resale Prior to Effectiveness and Nasdaq-related Approvals

    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company has filed a registration statement on Form S-1 with the Securities and Exchange Commission (“SEC”) for the securities underlying the units sold in the Company’s private placement previously announced on February 2, 2017. None of the securities are available for resale until such registration statement is declaredmore...
  • 3/21/17 7:30 am EDT
    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it has appointed Dennis M. McGrath as its new Executive Vice President and Chief Financial Officer. Mr. McGrath brings over thirty years of corporate finance and executive experience to PAVmed, spanning both entrepreneurial and public company settings. Since 2000, Mr. McGrath has served in multiple executive leadership roles atmore...
  • 3/9/17 7:00 am EST

    Aggregate Private Placement Proceeds Exceed $2.5 Million

    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced the closing of approximately $1.0 million in additional financing, bringing the aggregate gross proceeds of our private placement to $2.5 million. The private placement consists of shares of Series A Convertible Preferred Stock and Series A Warrants. The initial closing was previously announced in February. Dr. Lishan Aklog,more...
  • 2/23/17 7:00 am EST

    Exchange to Provide Incentives for Long-Term Ownership by Existing and New Investors

    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMW) announced today that the Company intends to effectuate a registered exchange offer (the “Exchange”) whereby PAVmed’s Common Stock will become exchangeable for units (the “New Units”). Pursuant to the Exchange, each New Unit will be comprised of one share of Common Stock, identical to the currently outstanding Common Stock, and one newly-issued warrant (the “New Unit Warrant”). Each holder ofmore...

SEC Filings

Click Here to view PAVmed's SEC filings

INVESTOR PRESENTATION

Click Here to view PAVmed’s current Investor Presentation

PROXY MATERIALS

Click Here to view the Proxy Statement for PAVmed Inc 2017 Annual Meeting

Click Here to view the Annual Report for PAVmed Inc 2017 Annual Meeting